Generic Ozempic, Wegovy Coming to B.C. Soon
Health Canada reviews nine generic semaglutide submissions. Cheaper versions of Ozempic and Wegovy could soon improve access for diabetes and weight loss patients in British Columbia.
Category : Search result: obesity drug coverage
Montrealers Call for Media Focus on Iran Protests
Protesters in Montreal urged Canadian media to increase coverage of demonstrations in Iran during a rally on January 13, 2026. Learn about their demands and the local response.
Ozempic Goes Generic in Canada, Prices to Drop
Semaglutide, sold as Ozempic, is now off-patent in Canada. This move could slash costs by up to 75%, dramatically increasing access to the popular diabetes and weight-loss drug for Canadians.
Novo CEO: Obesity Pill Opens Doors to New Markets
Novo Nordisk's CEO says its new obesity pill will tap into millions not using GLP-1s due to needle fears. The drugmaker battles Eli Lilly and compounders in a massive market.
B.C. Decriminalization Pilot Faces Renewal Deadline
B.C. Premier David Eby must decide by month's end whether to extend the province's drug decriminalization pilot. We examine its impact, drawbacks, and what's next for users.
First Alzheimer's Fighting Infusion Delivered in Canada
A newly approved Alzheimer's drug has been administered for the first time in Canada, providing fresh hope to patients. However, significant questions about coverage costs remain unresolved.
B.C. woman pleads for government to cover MS drug
A British Columbia woman is calling on the provincial government to fund a new multiple sclerosis drug. Her plea highlights the critical gap in coverage for patients.
Saskatoon woman denied travel coverage for brain surgery
Tammy O'Brien, a Saskatoon woman on a fixed income, was denied travel cost coverage by the Saskatchewan Health Ministry for lifesaving brain surgery in Edmonton. NDP critics call the policy failure 'unprecedented.'
Ontario woman charged after P.E.I. drug seizures
A 25-year-old Ontario woman is facing drug charges following two significant seizures by police in Prince Edward Island last month. Get the latest details on the case.
Kilos Return Fast After Stopping Weight-Loss Drugs: Study
New research shows patients quickly regain weight after ending GLP-1 medications like Wegovy. Experts stress the need for long-term lifestyle strategies. Learn the findings.
Cle de Peau's $77 Concealer: A Canadian Review
A Canadian beauty writer with lifelong dark circles puts the cult-favourite Cle de Peau Beauté concealer to the test. Is the $77 price tag justified by its performance? Find out in this detailed review.
Edmonton man arrested in drug investigation
An Edmonton man faces charges after ALERT's organized crime unit seized drugs and cash in a raid on two homes. Get the details on the investigation.
London man charged in Lambton County drug seizure
A London resident faces charges after police seize millions in drugs in Lambton County. Get the latest details on the investigation and charges.
U.S. Approves Pill Version of Popular Weight-Loss Drug
U.S. regulators have greenlit a pill version of a leading weight-loss medication, potentially broadening treatment options. Learn about the approval and its implications.
OPP seizes $36K in drugs from Exeter home
Ontario Provincial Police confiscated approximately $36,000 worth of illegal narcotics from a residence in Exeter, South Huron. The raid also uncovered offence-related items and money.
Four charged in Church Point drug probe: RCMP
Nova Scotia RCMP charge four individuals in an ongoing drug investigation in Church Point. Get the latest details on the arrests and police efforts.
Lilly pill keeps weight off after injectable drugs in trial
New data shows Eli Lilly's oral weight-loss drug successfully maintains weight reduction after patients switch from injectable medications. A breakthrough for chronic obesity management.
Six arrested in Brant County drug bust
Ontario Provincial Police announce six arrests following a drug trafficking investigation in Brant County and Brantford. Seized items revealed. Read the latest details.
Stony Plain woman faces drug charges after RCMP bust
A woman from Stony Plain, Alberta, is facing multiple drug charges following the execution of an RCMP search warrant. Get the details on the police operation and charges.
Tapper: Media Failed to Ask Enough on Biden Health
CNN's Jake Tapper reflects on media's handling of Biden's cognitive health questions and how it's changing his coverage of Trump's second term. Get the full story.
Trump sues BBC for $10B over edited documentary
Former U.S. President Donald Trump files a massive $10 billion lawsuit against the BBC for alleged defamation and election interference. Get the latest on this high-stakes media legal battle.
CDC Ends Newborn Hep B Vaccine Rule, Canadian Coverage Stays
The CDC has voted to end universal hepatitis B vaccination for newborns. Canadian officials and insurers confirm coverage will not change. Details on the policy shift and its implications.
Hims & Hers Acquires Livewell for Canadian Expansion
U.S. telehealth giant Hims & Hers acquires Canadian platform Livewell, positioning itself to launch generic semaglutide (Ozempic) in Canada as Novo Nordisk's patent lapses. The move targets a market where two-thirds of adults face weight-related health ch
Calgary teen charged in connection with suspected fatal overdoses
A Calgary teenager is facing multiple drug-related charges following suspected fatal overdoses. Police investigation leads to serious charges. Read the latest on this developing case.
LHSC ends unlimited mental health benefits for some staff
London Health Sciences Centre is changing its mental health benefits for certain employee groups, moving from unlimited coverage to a managed program. Learn about the details and implications.
Insurers Stress Commercial Coverage Need Despite Rising Costs
Canadian insurers highlight the critical importance of commercial insurance for businesses, even as premiums increase. Experts warn that adequate coverage is essential for financial resilience.
Novo Nordisk to test obesity drug CagriSema in children
Novo Nordisk, maker of Wegovy, plans clinical trials for its experimental obesity medication CagriSema in overweight children and adolescents. Get the latest details on this significant development in pediatric health.
Belly Fat Linked to Dangerous Heart Changes in Men
New research reveals abdominal fat, particularly in men, is strongly linked to dangerous heart remodelling. Learn the risks and what the data means for Canadians.
WHO Backs GLP-1 Treatments for Obesity Epidemic
The World Health Organization has officially endorsed GLP-1 receptor agonist treatments, including drugs like Ozempic, as a key tool to tackle the global obesity epidemic. Learn what this means for public health.
Eli Lilly cuts price of obesity drug Zepbound
Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.
Page 1 of 4